Fact CheckerSign in

NCT05157477Recruiting

Targeting the Sensory Disturbance in Autism Spectrum Disorder

Targeting the Sensory Disturbance in Autism Spectrum Disorder: The Effectiveness of Cognitive-behavior Therapy-based Virtual Reality Exposure Program

Source: ClinicalTrials.gov · Last updated 31 Jul 2026

Brief summary (registry, in English)

This study aims to establish a cognitive-behavior therapy (CBT) based virtual exposure (VR) exposure program to train ASD adults coping with everyday sensory scenarios. Through the practice and training, the ASD participants may learn the strategy to deal with the common sensory scenarios and master the anxiety around the exposure. The anticipatory anxiety and the maladaptive behaviors may be decreased along with the process of desensitization, while the functional impairment related to sensory sensitivity can partly be recovered.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
90 (estimated)
First submitted
2 Dec 2021
Start date
17 Jun 2020
Primary completion date
31 Dec 2027
Lead sponsor
National Taiwan University Hospital
Diseases
Autism
NCT number
NCT05157477

What you commit to

  • Study type: Interventional
  • Planned participants: 90
  • From 17 Jun 2020 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis) or neurological diseases;
  • visual impairment and/or hearing impairment that would preclude participation in the CBT-based VR exposure program

Who the study is looking for

  • young adult aged between 18 and 45 years who had a diagnosis of ASD from a licensed mental health or medical professional based on DSM-5;
  • has sensory and social problems as reported by the participant and the caregiver;
  • is motivated to participate in the treatment;
  • is fluent in Chinese;
  • has a full-scale IQ \> 70 on WAIS-IV;
  • scored ≧ 26 on the caregiver-reported Autism Spectrum Quotient (AQ), indicating clinical impairment associated with ASD.

Age in the registry: 20 years to 45 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.